Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / MED BREAKTHGH
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
1,467,528
-
Shares change
-
-37,746
-
Total reported value, excl. options
-
$71,788,731
-
Value change
-
-$1,972,757
-
Put/Call ratio
-
33%
-
Number of buys
-
28
-
Number of sells
-
-27
-
Price
-
$48.91
Significant Holders of ALPS ETF TR - MED BREAKTHGH (SBIO) as of Q2 2021
79 filings reported holding SBIO - ALPS ETF TR - MED BREAKTHGH as of Q2 2021.
ALPS ETF TR - MED BREAKTHGH (SBIO) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,467,528 shares
.
Largest 10 shareholders include MORGAN STANLEY (232,461 shares), BANK OF AMERICA CORP /DE/ (204,835 shares), UBS Group AG (192,768 shares), WELLS FARGO & COMPANY/MN (171,971 shares), NTV Asset Management LLC (74,484 shares), Cardan Capital Partners, LLC (68,670 shares), Tower Research Capital LLC (TRC) (51,955 shares), LPL Financial LLC (46,523 shares), CITADEL ADVISORS LLC (45,485 shares), and COMMONWEALTH EQUITY SERVICES, LLC (38,804 shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.